
POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
Author(s) -
Chen YanXing,
Wang ZiXian,
Yuan ShuQiang,
Jiang TengJia,
Huang YouSheng,
Xu RuiHua,
Wang Feng,
Zhao Qi
Publication year - 2021
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.524
Subject(s) - biology , dna polymerase , mutation , cancer research , cancer , genetics , gene